5 Recent Dementia Research Advances — From Blood Tests and Lithium to Lifestyle Changes

In recent years, significant progress has been made in the field of dementia research. By 2060, it is expected that there will be a million new dementia diagnoses each year. To combat this growing issue, researchers have developed innovative therapies focused on intervention, amyloid-beta, and neuroinflammation.

One groundbreaking development is the advancement of blood-based biomarkers for detecting Alzheimer's disease. Previously, clinicians relied on expensive and invasive procedures like PET scans or spinal taps. However, new blood tests using biomarkers such as phosphorylated tau (p-tau217) have emerged, allowing for easier and less invasive diagnosis. This is a major breakthrough, as Christopher Weber, a clinical psychologist and senior director of global scientific initiatives for the Alzheimer's Association, noted.

Another promising area is lifestyle intervention. In 2025, the US POINTER randomized clinical trial demonstrated that structured programs involving nutrition, physical exercise, cognitive stimulation, and socialization can help older adults maintain better cognitive functioning. After two years, participants in the guided group showed greater global cognition compared to those who were self-guided. This suggests that lifestyle changes could potentially slow memory loss.

The research also highlights the role of anti-amyloid therapies. Drugs like lecanemab and donanemab, which aim to remove amyloid plaques in the brain, have shown promising results in clinical trials. Although these treatments are not cures, they can reduce plaques, improve brain function, and enhance quality of life for individuals with early Alzheimer's disease.

Additionally, scientists have discovered the crucial role of lithium in protecting the brain from neurodegeneration. Lithium, naturally occurring in the brain, helps all major brain cell types maintain function. Early loss of lithium in Alzheimer's disease may contribute to its progression. The discovery of lithium deficiency and its potential as a prevention mechanism opens up new possibilities for treatment.

Lastly, researchers are exploring neuroinflammation therapies. Tau proteins, which support neurons in the brain, can malfunction and become clumpy, leading to inflammation and degeneration. The focus is shifting towards tau therapies, with the understanding that combining multiple strategies may prove more effective than single-target approaches, similar to treatments for cancer and cardiovascular diseases.